Created at	Source	Raw Value	Validated value
May 16, 2025, 8 a.m.	usa	Number of Subjects Experiencing TEAEs;Number of Subjects Experiencing TESAEs	Number of Subjects Experiencing TEAEs;Number of Subjects Experiencing TESAEs
Oct. 27, 2020, 11:31 p.m.	usa	Efficacy as measured by median time to hospital discharge (Part 2);Safety and Tolerability of ANA001 as measured by the incidence of treatment emergent adverse events (TEAE's) (Part 1 and Part 2)	Efficacy as measured by median time to hospital discharge (Part 2);Safety and Tolerability of ANA001 as measured by the incidence of treatment emergent adverse events (TEAE's) (Part 1 and Part 2)